the cibis trial ( cardiac insufficiency bisoprolol study ) has been launched in europe to answer the question of the potential benefit on prognosis of beta-blockade therapy in heart failure from any etiology , especially ischemic chf .
C0053799
bisoprolol
C0018802
chf